Table 1 Frameworks for appraising applicability of studies
Framework and/or First Author | Journal | Framework Focus | Year of Publication | |
|---|---|---|---|---|
AGREE I | Cluzeau et al. [29] | Quality and Safety in Health Care | Quality of CPG | 2003 |
AGREE II | Brouwers et al. [30] | Canadian Medical Association J | Â | 2010 |
AGREE-REX | Brouwers et al. [31] | JAMA Network Open | Quality of CPG recommendations | 2020 |
ASTAIRE | Cambon et al. [32] | BMC Public Health | Transferability of health promotion interventions | 2013 |
EVAT | Khorsan et al. [33] | Evidence-Based Complementary and Alternative Medicine | Evidence for clinical decision-making | 2014 |
GRADE | Guyatt et al. [11] | British Medical Journal | Quality of evidence and strength of recommendations | 2008 |
GRADE EtD | ||||
 Clinical recommendations | British Medical Journal | Evidence usage in a structured and transparent way to inform and adapt clinical and public health decisions | 2016 2016 | |
 Coverage decisions | Parmelli et al. [35] | Int J of Tech Assessm in Health Care | 2017 | |
 Diagnostic/screening tests | Schünemann et al. [36] | Journal of Clinical Epidemiology | 2017 | |
 Health system and public health | Moberg et al. [37] | Health Research Policy and Systems | 2018 | |
 Multi-intervention comparisons | Piggott et al. [38] | Journal of Clinical Epidemiology | 2021 | |
GRASP | Khalifa et al. [39] | BMC Medical Informatics and Decision Making | Predictive tools for clinical decision support | 2019 |
ISAT | Milat et al. [40] | Health Research Policy and Systems | Decision support tool for health policy makers and implementers | 2020 |
PRECIS | Thorpe et al. [41] | Canadian Medical Association Journal | Pragmatic vs. exploratory trials for trial designers | 2009 |
PR-Tool | Koppenaal et al. [42] | Journal of Clinical Epidemiology | Applicability of individual and SR of trials | 2011 |
PROBAST | Moons et al. [43] | Annals of Internal Medicine | Risk of bias and applicability of prediction model studies | 2019 |
RE-AIM | American Journal of Public Health Health Education Research | Evaluate and report on internal and external validity, and impact of health promotion programs | 1999 2006 | |
RoB 2 | Sterne et al. [7] | British Medical Journal | Risk of bias in randomized trials | 2019 |
RoBINS-I | Sterne et al. [6] | British Medical Journal | Risk of bias in non-randomised studies of interventions | 2016 |
STP | Lavis et al. [45] | Health Research Policy and Systems | Applicability of the findings of a systematic review | 2009 |
WHO-INTEGRATE EtD | Stratil et al. [46] | Cost Effectiveness and Resource Allocation | Decision criteria for health decision making | 2020 |
Almeida et al. [47] | Int J of Tech Assessm in Health Care | Translation of HTA evidence into policy | 2019 | |
Atkins et al. [48] | Journal of Clinical Epidemiology | Applicability when comparing medical interventions for SR | 2011 | |
Berger et al. [49] | Value in Health | Relevance and credibility of observational studies for health care decision making | 2014 | |
Bonell et al. [50] | British Medical Journal | Generalizability in trials of health interventions | 2006 | |
Bornhoft et al. [51] | BMC Medical Research Methodology | Evaluation of clinical studies on external and model validity | 2006 | |
Burford et al. [52] | Journal of Clinical Epidemiology | Applicability of findings in systematic reviews of complex interventions for SR | 2013 | |
Green et al. [17] | Evaluation and the Health Professions | Relevance, generalizability, and applicability of research | 2006 | |
Gruen et al. [53] | Bulletin of the World Health Org | Generalizability of studies in LMIC for SR | 2005 | |
Linan et al. [54] | Journal of Evidence-Based Medicine | Clinical applicability of CPG | 2020 | |
Polus et al. [55] | Int J of Tech Assessm in Health Care | Applicability of a technology in the context of HTA | 2017 | |